Gender and age differences in the metabolism of inorganic arsenic in a highly exposed population in Bangladesh

Environmental Research

Volumn 106, Issue 1, 2008, Pages 110-120

  Lindberg, Anna Lena ^a   Ekström, Eva Charlotte ^b   Nermell, Barbro ^a   Rahman, Mahfuzar ^c   Lönnerdal, Bo ^d   Persson, Lars Åke ^b   Vahter, Marie ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Age differences; Gender differences; Inorganic arsenic; Methylation; Urine

Indexed keywords

ARSENIC; DRINKING WATER; SEX HORMONE;

AGE STRUCTURE; ARSENIC; CONCENTRATION (COMPOSITION); DRINKING WATER; GENDER; INDUCTIVELY COUPLED PLASMA METHOD; METABOLISM; METHYLATION; NUTRITION; POLLUTION EXPOSURE; POLYMORPHISM; RURAL AREA; SEX HORMONE; SPECIATION (CHEMISTRY); URINE;

ADOLESCENT; AGED; AGING; ARTICLE; BANGLADESH; CHILD; FEMALE; GENETIC POLYMORPHISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MASS SPECTROMETRY; METABOLISM; METHYLATION; POPULATION EXPOSURE; PRIORITY JOURNAL; RURAL AREA; SEX DIFFERENCE; URINE LEVEL; WATER SUPPLY;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ARSENICALS; BANGLADESH; CHILD; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; FEMALE; HUMANS; MALE; MIDDLE AGED; RURAL POPULATION; SEX FACTORS; WATER POLLUTANTS, CHEMICAL;

ASIA; BANGLADESH; EURASIA; MATLAB; SOUTH ASIA;

EID: 36248949683     PISSN: 00139351     EISSN: 10960953     Source Type: Journal    
DOI: 10.1016/j.envres.2007.08.011     Document Type: Article

References (70)

1. Apostoli P., Bartoli D., Alessio L., and Buchet J.P. Biological monitoring of occupational exposure to inorganic arsenic. Occup. Environ. Med. 56 (1999) 825-832
2. Brosnan J.T., Jacobs R.L., Stead L.M., and Brosnan M.E. Methylation demand: a key determinant of homocysteine metabolism. Acta Biochim. Pol. 51 (2004) 405-413
3. Chakraborti D., Sengupta M.K., Rahman M.M., Ahamed S., Chowdhury U.K., Hossain M.A., Mukherjee S.C., Pati S., Saha K.C., Dutta R.N., and Quamruzzaman Q. Groundwater arsenic contamination and its health effects in the Ganga-Meghna-Brahmaputra plain. J. Environ. Monit. 6 (2004) 74N-83N
4. Chen Y.C., Guo Y.L., Su H.J., Hsueh Y.M., Smith T.J., Ryan L.M., Lee M.S., Chao S.C., Lee J.Y., and Christiani D.C. Arsenic methylation and skin cancer risk in southwestern Taiwan. J. Occup. Environ. Med. 45 (2003) 241-248
5. Chen Y.C., Su H.J., Guo Y.L., Hsueh Y.M., Smith T.J., Ryan L.M., Lee M.S., and Christiani D.C. Arsenic methylation and bladder cancer risk in Taiwan. Cancer Causes Control 14 (2003) 303-310
6. Chen H., Li S., Liu J., Diwan B.A., Barrett J.C., and Waalkes M.P. Chronic inorganic arsenic exposure induces hepatic global and individual gene hypomethylation: implications for arsenic hepatocarcinogenesis. Carcinogenesis 25 (2004) 1779-1786
7. Chen Y.C., Su H.J., Guo Y.L., Houseman E.A., and Christiani D.C. Interaction between environmental tobacco smoke and arsenic methylation ability on the risk of bladder cancer. Cancer Causes Control 16 (2005) 75-81
8. Clegg M.S., Keen C.L., Lonnerdal B., and Hurley L.S. Influence of ashing techniques on the analysis of trace elements in animal tissue. Biol. Trace Elem. Res. 3 (1981) 107-115
9. Concha G., Nermell B., and Vahter M.V. Metabolism of inorganic arsenic in children with chronic high arsenic exposure in northern Argentina. Environ. Health Perspect. 106 (1998) 355-359
10. Concha G., Vogler G., Lezcano D., Nermell B., and Vahter M. Exposure to inorganic arsenic metabolites during early human development. Toxicol. Sci. 44 (1998) 185-190
11. Csanaky I., Nemeti B., and Gregus Z. Dose-dependent biotransformation of arsenite in rats-not S-adenosylmethionine depletion impairs arsenic methylation at high dose. Toxicology 183 (2003) 77-91
12. Cui X., Wakai T., Shirai Y., Hatakeyama K., and Hirano S. Chronic oral exposure to inorganic arsenate interferes with methylation status of p16INK4a and RASSF1A and induces lung cancer in A/J mice. Toxicol. Sci. 91 (2006) 372-381
13. Cui X., Wakai T., Shirai Y., Yokoyama N., Hatakeyama K., and Hirano S. Arsenic trioxide inhibits DNA methyltransferase and restores methylation-silenced genes in human liver cancer cells. Hum. Pathol. 37 (2006) 298-311
14. De Kimpe J., Cornelis R., and Vanholder R. In vitro methylation of arsenite by rabbit liver cytosol: effect of metal ions, metal chelating agents, methyltransferase inhibitors and uremic toxins. Drug Chem. Toxicol. 22 (1999) 613-628
15. Del Razo L.M., Garcia-Vargas G.G., Vargas H., Albores A., Gonsebatt M.E., Montero R., Ostrosky-Wegman P., Kelsh M., and Cebrian M.E. Altered profile of urinary arsenic metabolites in adults with chronic arsenicism. A pilot study. Arch. Toxicol. 71 (1997) 211-217
16. Drobna Z., Waters S.B., Devesa V., Harmon A.W., Thomas D.J., and Styblo M. Metabolism and toxicity of arsenic in human urothelial cells expressing rat arsenic (+3 oxidation state)-methyltransferase. Toxicol. Appl. Pharmacol. 207 (2005) 147-159
17. Fischer L.M., daCosta K.A., Kwock L., Stewart P.W., Lu T.S., Stabler S.P., Allen R.H., and Zeisel S.H. Sex and menopausal status influence human dietary requirements for the nutrient choline. Am. J. Clin. Nutr. 85 (2007) 1275-1285
18. Foa V., Colombi A., Maroni M., Buratti M., and Calzaferri G. The speciation of the chemical forms of arsenic in the biological monitoring of exposure to inorganic arsenic. Sci. Tot. Environ. 34 (1984) 241-259
19. Gamble M.V., Liu X., Ahsan H., Pilsner R., Ilievski V., Slavkovich V., Parvez F., Levy D., Factor-Litvak P., and Graziano J.H. Folate, homocysteine, and arsenic metabolism in arsenic-exposed individuals in Bangladesh. Environ. Health Perspect. 113 (2005) 1683-1688
20. Hare R.S. Endogenous creatinine in serum and urine. Proc. Soc. Exp. Biol. Med. 74 (1950) 148-151
21. Holm, P.I., Hustad, S., Ueland, P.M., Vollset, S.E., Grotmol, T., Schneede, J., 2007. Modulation of the homocysteine-betaine relationship by methylenetetrahydrofolate reductase 677 C->T genotypes and B-vitamin status in a large scale epidemiological study. J. Clin. Endocrinol. Metab. doi:10.1210/jc.2006-1471.
22. Hopenhayn C., Huang B., Christian J., Peralta C., Ferreccio C., Atallah R., and Kalman D. Profile of urinary arsenic metabolites during pregnancy. Environ. Health Perspect. 111 (2003) 1888-1891
23. Hopenhayn-Rich C., Biggs M.L., Kalman D.A., Moore L.E., and Smith A.H. Arsenic methylation patterns before and after changing from high to lower concentrations of arsenic in drinking water. Environ. Health Perspect. 104 (1996) 1200-1207
24. Hopenhayn-Rich C., Biggs M.L., Smith A.H., Kalman D.A., and Moore L.E. Methylation study of a population environmentally exposed to arsenic in drinking water. Environ. Health Perspect. 104 (1996) 620-628
25. Hsueh Y.M., Chiou H.Y., Huang Y.L., Wu W.L., Huang C.C., Yang M.H., Lue L.C., Chen G.S., and Chen C.J. Serum beta-carotene level, arsenic methylation capability, and incidence of skin cancer. Cancer Epidemiol. Biomarkers Prev. 6 (1997) 589-596
26. Hsueh Y.M., Ko Y.F., Huang Y.K., Chen H.W., Chiou H.Y., Huang Y.L., Yang M.H., and Chen C.J. Determinants of inorganic arsenic methylation capability among residents of the Lanyang Basin, Taiwan: arsenic and selenium exposure and alcohol consumption. Toxicol. Lett. 137 (2003) 49-63
27. Hughes M.F., and Kenyon E.M. Dose-dependent effects on the disposition of monomethylarsonic acid and dimethylarsinic acid in the mouse after intravenous administration. J. Toxicol. Environ. Health A 53 (1998) 95-112
28. IARC, 2004. Some drinking-water disinfectants and contaminants, including arsenic. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. IARC Press, Lyon, p. 512.
29. Jakariya M., Rahman M., Chowdhury A., Rahman M., Yunus M., Bhiuya A., Wahed M.A., Bhattacharya P., Jacks G., Vahter M., and Persson L.A. Sustainable safe water options in Bangladesh: experiences from the arsenic project in Matlab (AsMat). In: Bundschuh J., et al. (Ed). Natural Arsenic in Groundwater: Occurrence, Remediation and Management (2005), Taylor & Francis Group, London 319-330
30. Kalman D.A., Hughes J., van Belle G., Burbacher T., Bolgiano D., Coble K., Mottet N.K., and Polissar L. The effect of variable environmental arsenic contamination on urinary concentrations of arsenic species. Environ. Health Perspect. 89 (1990) 145-151
31. Khan M.M., Aklimunnessa K., Kabir M.A., Kabir M., and Mori M. Tobacco consumption and its association with illicit drug use among men in Bangladesh. Addiction 101 (2006) 1178-1186
32. Kuczmarski, R.J., Ogden, C.L., Grummer-Strawn, L.M., Flegal, K.M., Guo, S.S., Wei, R., Mei, Z., Curtin, L.R., Roche, A.F., Johnson, C.L., 2000. CDC growth charts: United States. Adv. Data, pp. 1-27.
33. Kurttio P., Komulainen H., Hakala E., Kahelin H., and Pekkanen J. Urinary excretion of arsenic species after exposure to arsenic present in drinking water. Arch. Environ. Contam. Toxicol. 34 (1998) 297-305
34. Lindberg A.L., Goessler W., Gurzau E., Koppova K., Rudnai P., Kumar R., Fletcher T., Leonardi G., Slotova K., Gheorghiu E., and Vahter M. Arsenic exposure in Hungary, Romania and Slovakia. J. Environ. Monit. 8 (2006) 203-208
35. Lindberg A.L., Kumar R., Goessler W., Thirumaran R., Gurzau E., Koppova K., Rudnai P., Leonardi G., Fletcher T., and Vahter M. Metabolism of low dose inorganic arsenic in a Central European population-influence of gender and genetic polymorphism. Environ. Health Perspect. 115 (2007) 1081-1086
36. Lindberg A.L., Goessler W., Grander M., Nermell B., and Vahter M. Evaluation of the three most commonly used analytical methods for determination of inorganic arsenic and its metabolites in urine. Toxicol. Lett. 168 (2007) 310-318
37. Loffredo C.A., Aposhian H.V., Cebrian M.E., Yamauchi H., and Silbergeld E.K. Variability in human metabolism of arsenic. Environ. Res. 92 (2003) 85-91
38. Maki-Paakkanen J.K.P., Paldy A., and Pekkanen J. Association between the clastogenic effect in peripheral lymphocytes and human exposure to arsenic through drinking water. Environ. Mol. Mutagen 32 (1998) 301-313
39. Milton A.H., Hasan Z., Shahidullah S.M., Sharmin S., Jakariya M.D., Rahman M., Dear K., and Smith W. Association between nutritional status and arsenicosis due to chronic arsenic exposure in Bangladesh. Int. J. Environ. Health Res. 14 (2004) 99-108
40. Mitra S.R., Mazumder D.N., Basu A., Block G., Haque R., Samanta S., Ghosh N., Smith M.M., von Ehrenstein O.S., and Smith A.H. Nutritional factors and susceptibility to arsenic-caused skin lesions in West Bengal, India. Environ. Health Perspect. 112 (2004) 1104-1109
41. Nermell, B., Lindberg, A., Rahman, M., Berglund, M., Persson, L.A., Arifeen, S.E., Vahter, M., 2007. Adjusting urinary arsenic concentrations for variation in urine dilution by creatinine and specific gravity in malnourished people. Environ. Res., doi:10.1016/j.envres.2007.08.005.
42. Niculescu M.D., and Zeisel S.H. Diet, methyl donors and DNA methylation: interactions between dietary folate, methionine and choline. J. Nutr. 132 (2002) 2333S-2335S
43. Norin H., and Vahter M. A rapid method for the selective analysis of total urinary metabolites of inorganic arsenic. Scand. J. Work Environ. Health 7 (1981) 38-44
44. Petrick J.S., Ayala-Fierro F., Cullen W.R., Carter D.E., and Vasken Aposhian H. Monomethylarsonous acid (MMA(III)) is more toxic than arsenite in Chang human hepatocytes. Toxicol. Appl. Pharmacol. 163 (2000) 203-207
45. Pu Y.S., Yang S.M., Huang Y.K., Chung C.J., Huang S.K., Chiu A.W., Yang M.H., Chen C.J., and Hsueh Y.M. Urinary arsenic profile affects the risk of urothelial carcinoma even at low arsenic exposure. Toxicol. Appl. Pharmacol. 218 (2007) 99-106
46. Rahman M., Vahter M., Sohel N., Yunus M., Wahed M.A., Streatfield P.K., Ekström E.C., and Persson L.A. Arsenic exposure and age- and sex-specific risk for skin lesions: a population-based case-referent study in Bangladesh. Environ. Health Perspect. 114 (2006) 1847-1852
47. Rahman M., Vahter M., Wahed M.A., Sohel N., Yunus M., Streatfield P.K., El Arifeen S., Bhuiya A., Zaman K., Chowdhury A.M., Ekstrom E.C., and Persson L.A. Prevalence of arsenic exposure and skin lesions. A population based survey in Matlab, Bangladesh. J. Epidemiol. Community Health 60 (2006) 242-248
48. Reichard J.F., Schnekenburger M., and Puga A. Long term low-dose arsenic exposure induces loss of DNA methylation. Biochem. Biophys. Res. Commun. 352 (2007) 188-192
49. Schläwicke Engström, K., Broberg, K., Concha, G., Nermell, B., Warholm, M., Vahter, M., 2006. Genetic polymorphisms influencing arsenic metabolism-evidence from Argentina. Environ. Health Perspect. doi:10.1289/ehp.9734.
50. Steinmaus C., Carrigan K., Kalman D., Atallah R., Yuan Y., and Smith A.H. Dietary intake and arsenic methylation in a US population. Environ. Health Perspect. 113 (2005) 1153-1159
51. Steinmaus C., Bates M.N., Yuan Y., Kalman D., Atallah R., Rey O.A., Biggs M.L., Hopenhayn C., Moore L.E., Hoang B.K., and Smith A.H. Arsenic methylation and bladder cancer risk in case-control studies in Argentina and the United States. J. Occup. Environ. Med. 48 (2006) 478-488
52. Styblo M., Del Razo L.M., Vega L., Germolec D.R., LeCluyse E.L., Hamilton G.A., Reed W., Wang C., Cullen W.R., and Thomas D.J. Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch. Toxicol. 74 (2000) 289-299
53. Sudo N., Sekiyama M., Watanabe C., Bokul A.T., and Ohtsuka R. Gender differences in food and energy intake among adult villagers in northwestern Bangladesh: a food frequency questionnaire survey. Int. J. Food Sci. Nutr. 55 (2004) 499-509
54. Suwazono Y., Akesson A., Alfven T., Jarup L., and Vahter M. Creatinine versus specific gravity-adjusted urinary cadmium concentrations. Biomarkers 10 (2005) 117-126
55. Ueland P.M., Holm P.I., and Hustad S. Betaine: a key modulator of one-carbon metabolism and homocysteine status. Clin. Chem. Lab. Med. 43 (2005) 1069-1075
56. Wahed M.A., Chowdhury D., Nermell B., Khan S.I., Ilias M., Rahman M., Persson L.A., and Vahter M. A modified routine analysis of arsenic content in drinking-water in Bangladesh by hydride generation-atomic absorption spectrophotometry. J. Health Popul. Nutr. 24 (2006) 36-41
57. Vahter M. Variation in human metabolism of arsenic. In: Chappell W.R., et al. (Ed). Arsenic Exposure and Health Effects (1999), Elsevier, Oxford 267-279
58. Vahter M. Mechanisms of arsenic biotransformation. Toxicology 181,182 (2002) 211-217
59. Vahter M., and Marafante E. Effects of low dietary intake of methionine, choline or proteins on the biotransformation of arsenite in the rabbit. Toxicol. Lett. 37 (1987) 41-46
60. Vahter M., Friberg L., Rahnster B., Nygren A., and Nolinder P. Airborne arsenic and urinary excretion of metabolites of inorganic arsenic among smelter workers. Int. Arch. Occup. Environ. Health 57 (1986) 79-91
61. Vega L., Styblo M., Patterson R., Cullen W., Wang C., and Germolec D. Differential effects of trivalent and pentavalent arsenicals on cell proliferation and cytokine secretion in normal human epidermal keratinocytes. Toxicol. Appl. Pharmacol. 172 (2001) 225-232
62. WHO, 2000. Obesity: Preventing and Managing the Global Epidemic. WHO Technical Report Series 894. World Health Organization, Geneva.
63. WHO, 2001. EHC 224, Arsenic and Arsenic Compounds. Environmental Health Criteria. World Health Organization, Geneva, p. 521.
64. WHO, 2003. Arsenic in drinking-water. Background document for preparation of WHO Guidelines for drinking-water quality. World Health Organization, Geneva, pp. (WHO/SDE/WSH/03.04/75).
65. WHO, UNICEF, 1995. A picture of health?-A review and annotated bibliography of the health of young people in developing countries. World Health Organization, pp. WHO/FHE/ADH/95.4
66. Williams P.N., Price A.H., Raab A., Hossain S.A., Feldmann J., and Meharg A.A. Variation in arsenic speciation and concentration in paddy rice related to dietary exposure. Environ. Sci. Technol. 39 (2005) 5531-5540
67. Wyss M., and Kaddurah-Daouk R. Creatine and creatinine metabolism. Physiol. Rev. 80 (2000) 1107-1213
68. Yu R.C., Hsu K.H., Chen C.J., and Froines J.R. Arsenic methylation capacity and skin cancer. Cancer Epidemiol. Biomarkers Prev. 9 (2000) 1259-1262
69. Zhang Z., Deng C., Lu Q., and Richardson B. Age-dependent DNA methylation changes in the ITGAL (CD11a) promoter. Mech. Ageing Dev. 123 (2002) 1257-1268
70. Zhou L.F., Zhu Y., Cui X.F., Xie W.P., Hu A.H., and Yin K.S. Arsenic trioxide, a potent inhibitor of NF-kappaB, abrogates allergen-induced airway hyperresponsiveness and inflammation. Respir. Res. 7 (2006) 146